Bioalmanac
Cerebrolysin
FPF-1070 · Cerebrolysinum
A pig-brain peptide preparation approved as a medicine in around forty countries. Decades of trials, and systematic reviews that still cannot find a clear benefit.
Storage
- Freeze-dried powder
- Supplied as a solution in ampoules rather than a powder. Store below 25 °C, protected from light.
- After mixing
- Use immediately once an ampoule is opened. It contains no preservative.
- Long-term, frozen
- Do not freeze.
Reconstitution — 215.2 mg vial, 215200 mcg dose
On a 1 mL U-100 syringe. Check every figure against your own vial before drawing.
| Water added | Concentration | Volume to draw | Units | Doses per vial |
|---|---|---|---|---|
| 1 mL | 215.2 mg/mL | 1 mL | 100 units | 1 |
| 2 mL | 107.6 mg/mL | — | Exceeds a 1 mL barrel | — |
| 3 mL | 71.733 mg/mL | — | Exceeds a 1 mL barrel | — |
| 5 mL | 43.04 mg/mL | — | Exceeds a 1 mL barrel | — |
Dose ranges reported in sources
Descriptions of what sources report, not recommendations.
| Goal | Range | Frequency | Source |
|---|---|---|---|
| Acute stroke, as studied | 2152000–6456000 mcg | Once daily for 10 to 21 days as a course | Clinical trial |
| Dementia, as studied | 1076000–3228000 mcg | Daily for 4 weeks, in courses repeated over a year | Clinical trial |
When to stop
- Any allergic response: rash, hives, facial swelling or difficulty breathing. Seek urgent care — this is an animal-derived biological product and anaphylactoid reactions are documented.
- Agitation, confusion or marked dizziness during or after an infusion.
- Fever, or an injection site that becomes hot, spreading or produces pus.
- Seizure activity, in anyone with a seizure history.
Use your browser’s print dialog and choose “Save as PDF”. This block is hidden when printed.